References
- Verwaal VJ, van Ruth S, de Bree E, et al. 2003. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–43.
- Sugarbaker PH. 1995. Peritonectomy procedures. Ann Surg 221:29–42.
- Glehen O, Kwiatkowski F, Sugarbaker PH, et al. 2004. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–92.
- Kusamura S, Baratti D, Younan R, et al. 2007. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol 14:2550–8.
- Canda AE, Sokmen S, Terzi C, et al. 2013. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 20:1082–7.
- Khrunin A, Ivanova F, Moisseev A, et al. 2012. Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins. Pharmacogenomics 13:171–8.
- Taguchi T, Nazneen A, Abid MR, Razzaque MS. 2005. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107–21.
- McKeage MJ. 2005. New-generation platinum drugs in the treatment of cisplatin-resistant cancers. Expert Opin Investig Drugs 14:1033–46.
- Sonoda A, Nitta N, Ohta S, et al. 2006. Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system. Gan to Kagaku Ryoho Cancer & Chemotherapy 33:951–7.
- Karkouti K. 2012. Transfusion and risk of acute kidney injury in cardiac surgery. Br J Anaesth 109(Suppl 1):i29–38.
- Parolari A, Pesce LL, Pacini D, et al. 2012. Risk factors for perioperative acute kidney injury after adult cardiac surgery: role of perioperative management. Ann Thorac Surg 93:584–91.
- Karkouti K, Wijeysundera DN, Yau TM, et al. 2012. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial. Anesthesiology 116:613–21.
- Baek JH, D'Agnillo F, Vallelian F, et al. 2012. Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J Clin Investig 122:1444–58.
- Lannan KL, Sahler J, Spinelli SL, et al. 2013. Transfusion immunomodulation – the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis 50:61–8.
- Faluyi OO, Masinghe SP, Hayward RL, Clive S. 2012. Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment. Med Oncol 29:755–60.